Related Experiment Video
Updated: Jan 28, 2026
11:14
Designing Silk-silk Protein Alloy Materials for Biomedical Applications
Published on: August 13, 2014
18.9K
Microstructural Study of Some Mg-Ca-Sr Based Alloys with Medical Applicability
Gabriela Leață1, Fabian Cezar Lupu2, Ion Ciucă3
1Faculty of Dental Medicine, "Dunarea de Jos" University, Galati, Romania.
Current Health Sciences Journal
|January 26, 2026
Summary
This study characterizes magnesium-calcium-strontium alloys for biodegradable medical implants. The research found these alloys exhibit homogeneous microstructures, paving the way for advanced orthopedic and maxillofacial applications.
Area of Science:
- Biomaterials Science
- Materials Engineering
- Medical Device Development
Background:
- Biodegradable biomaterials are essential for advancing medical treatments.
- Magnesium-based alloys offer promising properties for medical implants.
- Understanding alloy microstructure is key to their clinical success.
Purpose of the Study:
- To investigate the microstructural characteristics of Mg-Ca-Sr alloys.
- To evaluate alloys with varying strontium content for medical applications.
- To assess the suitability of these alloys as biodegradable medical implants.
Main Methods:
- Five Mg-Ca-Sr alloy formulations were prepared.
- Alloys were cast using induction furnace under an argon atmosphere.
- Microstructural analysis was conducted using optical and scanning electron microscopy.
Main Results:
- Homogeneous microstructures were observed across all alloy formulations.
- The alloys were found to be free of porosity.
- Microstructural integrity was confirmed for potential implant use.
Conclusions:
- Mg-Ca-Sr alloys exhibit favorable microstructural properties for medical applications.
- These alloys show potential for use in orthopedic and maxillofacial surgery.
- The research supports the development of novel biodegradable medical devices.
Related Concept Videos
01:23Inhaled Medications
785
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
785
01:18Endocarditis III: Medical Management
237
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
237
01:14Myocarditis III: Medical Management
205
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
205
01:17Pericarditis III: Medical Management
338
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
338
01:30Heart Failure V: Medical Management
267
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
267
01:25Mitral Regurgitation III: Medical Management
324
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
324